We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-6 of 6

The USMCA: What does it mean for patents and the pharmaceutical industry?
  • Gowling WLG
  • USA, Canada
  • October 5 2018

In a joint statement on September 30, 2018, the United States and Canadian Governments announced that they reached an agreement, alongside Mexico, on


Northern exposure?
  • Gowling WLG
  • USA, Canada
  • April 4 2013

Davit Akman and John Norman suggest that a recently commenced investigation into alleged "product switching" and statements by the Interim


U.S. patients receive greater access to unapproved medications
  • Gowling WLG
  • USA
  • August 21 2009

Seriously ill patients will have greater and easier access to unapproved medicines due to new USFDA regulations.


U.S. bill considers access to Canadian pharmaceuticals
  • Gowling WLG
  • USA, Canada
  • July 27 2009

Recently, the U.S. Senate amended the $43 billion Department of Homeland Securities Bill to allow Americans to purchase prescription drugs from Canadian internet pharmacies.


John Norman PhD
  • Gowling WLG